NASDAQ:MMSI - Nasdaq - US5898891040 - Common Stock - Currency: USD
MERIT MEDICAL SYSTEMS INC
NASDAQ:MMSI (1/23/2025, 9:18:58 PM)
After market: 103.67 0 (0%)103.67
-1.06 (-1.01%)
The current stock price of MMSI is 103.67 USD. In the past month the price increased by 5.55%. In the past year, price increased by 32.71%.
2024 preliminary unaudited revenue in the range of approximately $1.355 billion - $1.357 billion, up approximately 7.7% - 7.9% year-over-year2024...
Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, 2025 ...
SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of...
Reddit initiated, GE Vernova downgraded: Wall Street's top analyst calls
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.51 | 44.53B | ||
COO | COOPER COS INC/THE | 25.86 | 19.10B | ||
ALGN | ALIGN TECHNOLOGY INC | 25.2 | 17.53B | ||
SOLV | SOLVENTUM CORP | 17.69 | 12.72B | ||
LNTH | LANTHEUS HOLDINGS INC | 14.07 | 6.79B | ||
BLCO | BAUSCH + LOMB CORP | 27.62 | 5.93B | ||
ICUI | ICU MEDICAL INC | 29.42 | 4.09B | ||
XRAY | DENTSPLY SIRONA INC | 10.51 | 3.86B | ||
HAE | HAEMONETICS CORP/MASS | 17.86 | 3.66B | ||
NEOG | NEOGEN CORP | 29.35 | 2.54B | ||
UFPT | UFP TECHNOLOGIES INC | 37.45 | 2.01B | ||
RXST | RXSIGHT INC | N/A | 1.31B |
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,950 full-time employees. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.
MERIT MEDICAL SYSTEMS INC
1600 West Merit Park Way
South Jordan UTAH 84095 US
CEO: Fred P. Lampropoulos
Employees: 6950
Company Website: https://www.merit.com/
Investor Relations: https://www.merit.com/investors/
Phone: 18012531600
The current price of MMSI is 103.67 USD.
The exchange symbol of MERIT MEDICAL SYSTEMS INC is MMSI and it is listed on the Nasdaq exchange.
MMSI is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MMSI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MMSI.
MMSI does not pay a dividend.
The PE ratio for MMSI is 30.85. This is based on the reported non-GAAP earnings per share of 3.36 and the current share price of 103.67 USD.
The outstanding short interest for MMSI is 4.23% of its float.
ChartMill assigns a technical rating of 10 / 10 to MMSI. When comparing the yearly performance of all stocks, MMSI is one of the better performing stocks in the market, outperforming 81.33% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MMSI. While MMSI has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months MMSI reported a non-GAAP Earnings per Share(EPS) of 3.36. The EPS increased by 12.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.05% | ||
ROA | 5.05% | ||
ROE | 9.07% | ||
Debt/Equity | 0.57 |
ChartMill assigns a Buy % Consensus number of 85% to MMSI. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 13.63% and a revenue growth 7.59% for MMSI